The FDA has approved vonoprazan (Voquezna), a new daily treatment for heartburn associated with GERD in adults. andreswd/Getty Images Adults with a certain type of heartburn now have another option ...

Turmeric was found to improve indigestion symptoms similarly to a common medicine in a study. Turmeric is commonly used as an indigestion treatment in Southeast Asia. But this single study isn't ...

EDEN PRAIRIE, Minn., Nov. 3, 2023 /PRNewswire/ -- Aplos Medical (formerly CT Resources), developer of the next generation Gastroesophageal Reflux Disease (GERD) treatment, proudly announces the ...

FLORHAM PARK, N.J., Dec. 06, 2023 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal ...

This retrospective study shows that among nearly 160,000 patients with pulmonary hypertension (PH), those who also had gastroesophageal reflux disease (GERD) had lower rates of morbidity and mortality ...

VOQUEZNA, the first and only FDA-approved potassium-competitive acid blocker (PCAB), is now available through major retail pharmacies and BlinkRx, an end-to-end digital fulfillment channel VOQUEZNA ...

The FDA approved vonoprazan (Voquezna) as a daily treatment for heartburn associated with non-erosive gastroesophageal reflux disease (GERD) in adults. GERD is a condition in which acidic stomach ...

This informational guide, part of PS's Condition Center, lays out the realities of this health concern: what it is, what it can look like, and strategies that medical experts say are proven to help.

Broader adoption of MUSE strengthens Medigus' growth potential in Europe following completion of several procedures in leading healthcare institutions Medigus Ltd. (TASE: MDGS), a medical device ...